NCT03117361 2020-12-02
Trial of Plitidepsin (AplidinĀ®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide
PharmaMar
Phase 2 Terminated
Clinical Trials
4 trialsNCT01102426 2020-11-10
ADMYRE
PharmaMar
Phase 3 Completed
NCT02100657 2020-10-12
Study of Plitidepsin (AplidinĀ®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma
PharmaMar
Phase 1 Completed
NCT00229203 2009-12-24
A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma
PharmaMar
Phase 2 Completed